Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
pfizer
aducanumab
bristol-myers squibb
fda
merck
nash
ngm biopharmaceuticals
protein degradation
renaissance capital
acc
acquisition
What
week
4
×
bio
roundup
biogen
drug
ipo
life
medical
news
science
adu
aducanumab
alzheimer’s
amyloid
angst
approved
arena’s
bagged
beats
bids
billions
biogen’s
biotechs
bounty
brammer
chose
cig
close
comeback
companies
company
complicated
corner
deals
delivered
depression
device
dire
effects
expressing
Language
Current search:
celgene
×
week
×
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
